Complementary and alternative medicine use and hormonal therapy initiation in women with hormone receptor-positive breast cancer: The BQUAL study. | 2017 ASCO Annual Meeting Abstracts

e13097 Complementary and alternative medicine use and hormonal therapy initiation in women with hormone receptor-positive breast cancer: The BQUAL study. Heather Greenlee, Alfred I. Neugut, Zaixing Shi, Grace Hillyer, Donna Buono, Jeanne S. Mandelblatt, Janise M. Roh, Isaac J. Ergas, Marilyn L. Kwan, Marion Lee, Wei-Yann Tsai, Lois E. Lamerato, Lawrence H. Kushi, Dawn L. Hershman; Columbia University Medical Center, New York, NY; Columbia College of Physicians and Surgeons, New York, NY; Columbia University College of Physicians and Surgeons, New York, NY; Mailman School of Public Health, Columbia University, New York, NY; Georgetown University Medical Center, Washington, DC; Division of Research, Kaiser Permanente Northern California, Oakland, CA; University of California, San Francisco, San Francisco, CA; Henry Ford Health System, Detroit, MI

Source : Complementary and alternative medicine use and hormonal therapy initiation in women with hormone receptor-positive breast cancer: The BQUAL study. | 2017 ASCO Annual Meeting Abstracts

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *